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Introduction
Despite a well-established association between maternal asthma and adverse pregnancy 91 outcomes, knowledge of the mechanisms underlying these effects remains limited, largely 92 because investigations have been restricted to clinical studies. Understanding the relative 93 contributions of asthma severity, exacerbations and treatment to adverse pregnancy, fetal and 94 neonatal outcomes from investigations of clinical cohorts is difficult since it is ethically 95 impossible to randomise women to no treatment for their asthma during pregnancy.
96
Mechanistic information to guide the development of targeted therapies to prevent adverse 97 outcomes is often impossible to obtain from humans. Therefore, there is need for an animal 98 model of maternal asthma in which mechanistic studies can be undertaken. Sheep have long 99 been used to study pregnancy, fetal development and perinatal physiology, and a number of 100 medical interventions now routinely used in contemporary obstetrics and neonatology were 101 translated into practice from sheep experiments (Liggins, 1969; Gunn et al., 1997; Roelfsema 102 et al., 2004) .
104
It is possible to induce allergy and asthma in non-pregnant sheep using HDM allergen 105 (Bischof et al., 2003; Snibson et al., 2005; Bischof et al., 2008) , which results in a similar 106 lung phenotype to human asthma (James et al., 2012) , with eosinophil infiltration,
107
progressive loss of lung function, increased airway collagen deposition and thickening of 108 bronchial smooth muscle (Bischof et al., 2003; Snibson et al., 2005; Meeusen et al., 2009 ).
Outcomes were studied in only singleton-bearing ewes from each group. Singleton-bearing 159 non-allergic animals (control, n=9) included 5 sheep from the non-sensitised group plus 4 160 sheep from the sensitised group who did not show increases in IgE after the sensitisation 161 protocol, and the allergic group consisted of 11 singleton-bearing sheep (Figure 1 ).
163
Catheterisation of ewes and fetuses 164 Surgery was performed at 96-108 dGA (102 ± 1 dGA, mean ± SEM) on control (n=9) and 165 allergic (n=11) ewes identified by ultrasound as pregnant with singleton fetuses (Figure 1 ).
166
Food was withheld for 24 h prior to surgery, while drinking water remained unrestricted.
167
Prophylactic antibiotics (1g ampicillin sodium; Aspen Pharmacare Australia, Australia) were 168 administered intravenously (i.v.) to the ewe on the day of surgery. General anaesthesia was 169 induced by i.v. injection of 15-20 mg/kg sodium thiopentone (Pentothal; Ingelheim, Australia) and maintained by inhalation of 1.5-3% isoflurane (Delvet, Ceva, 171 Glenorie, NSW, Australia). Indwelling catheters were placed into the maternal and fetal 
Endoscopic airway challenges and characterisation of maternal immune responses

177
For endoscopic airway challenges, sheep were restrained unsedated in a custom-designed 178 body harness and a flexible fibre-optic endoscope Pentax Ltd, VIC, 179 Australia) was inserted into the lung via the nasal passage (Bischof et al., 2003) . In allergic 180 ewes, 5 ml of 100 μg/ml HDM extract (in sterile saline) was delivered as a bolus infusion into 181 each of the right and left caudal lobes of the lung, whilst control non-allergic ewes were 182 similarly challenged with the same volume of saline (Bischof et al., 2003; Meeusen et al., 183 2009 Biosystems, CA, USA) on a ViiA7 Fast Real-time PCR system (Applied Biosystems) as 276 previously described (Wang et al., 2011; Soo et al., 2012; McGillick et al., 2013) . because its levels were stable across fetal lung samples. Rps29 was amplified using the 287 following primers (F: CAGGGTTCTCGCTCTTGC R: ACTGGCGGCACATATTGAG).
288
Messenger RNA levels were normalised to expression of the reference gene Rps29 rRNA for 289 each fetus, and gene expression in fetuses from the allergic group was expressed relative to 290 the mean mRNA abundance for that gene in the control fetuses. of total placentome numbers in the allergic group ( Figure 6B) . Additionally, the total weight 358 of Type A placentomes was lower in placentae from allergic than in those from control ewes
359
( Figure 6C ). Figure 5B ). However, fetal weight relative to maternal weight 363 was 12% lower in the allergic group (P=0.038, Figure 5C ). The singleton fetuses collected at 
